drug nephrotoxicity

Open Access
Pharmacology behind Common Drug Nephrotoxicities
Mark A. Perazella

CJASN December 2018, 13 (12) 1897-1908; DOI: https://doi.org/10.2215/CJN.00150118

Add to Selected Citations
Open Access
Clinical Pharmacology in HIV Therapy
Mohamed G. Atta, Sophie De Seigneux and Gregory M. Lucas

CJASN October 2018, CJN.02240218; DOI: https://doi.org/10.2215/CJN.02240218

Add to Selected Citations
Open Access
Chimeric Antigen Receptor T Cell Therapy and the Kidney
Kenar D. Jhaveri and Mitchell H. Rosner

CJASN May 2018, 13 (5) 796-798; DOI: https://doi.org/10.2215/CJN.12871117

Add to Selected Citations
You have accessRestricted Access
Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury
Todd A. Miano, Ebbing Lautenbach, F. Perry Wilson, Wensheng Guo, Yuliya Borovskiy and Sean Hennessy

CJASN April 2018, 13 (4) 542-550; DOI: https://doi.org/10.2215/CJN.06980717

Add to Selected Citations
Open Access
Utility of Electronic Medical Record Alerts to Prevent Drug Nephrotoxicity
Melissa Martin and F. Perry Wilson

CJASN April 2018, CJN.13841217; DOI: https://doi.org/10.2215/CJN.13841217

Add to Selected Citations
You have accessRestricted Access
Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD
Meghan E. Sise, Elke Backman, Guillermo A. Ortiz, Gregory L. Hundemer, Nneka N. Ufere, Donald F. Chute, Joseph Brancale, Dihua Xu, Jessica Wisocky, Ming V. Lin, Arthur Y. Kim, Ravi Thadhani and Raymond T. Chung

CJASN October 2017, 12 (10) 1615-1623; DOI: https://doi.org/10.2215/CJN.02510317

Add to Selected Citations
You have accessRestricted Access
An Elderly Man with Fatigue, Dyspnea, and Kidney Failure
Andrew S. Bomback

CJASN May 2017, 12 (5) 836-838; DOI: https://doi.org/10.2215/CJN.13311216

Add to Selected Citations
You have accessRestricted Access
Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma
Rimda Wanchoo, Ala Abudayyeh, Mona Doshi, Amaka Edeani, Ilya G. Glezerman, Divya Monga, Mitchell Rosner and Kenar D. Jhaveri

CJASN January 2017, 12 (1) 176-189; DOI: https://doi.org/10.2215/CJN.06100616

Add to Selected Citations
You have accessRestricted Access
Vancomycin and the Risk of AKI: Now Clearer than Mississippi Mud
Thomas D. Nolin

CJASN December 2016, 11 (12) 2101-2103; DOI: https://doi.org/10.2215/CJN.11011016

Add to Selected Citations
You have accessRestricted Access
Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis
Christel Renoux, Lisa M. Lix, Valérie Patenaude, Lauren C. Bresee, J. Michael Paterson, Jean-Philippe Lafrance, Hala Tamim, Salaheddin M. Mahmud, Mhd. Wasem Alsabbagh, Brenda Hemmelgarn, Colin R. Dormuth, Pierre Ernst and the Canadian Network of Observational Drug Effect Studies (CNODES) Investigators

CJASN October 2015, 10 (10) 1716-1722; DOI: https://doi.org/10.2215/CJN.11271114

Add to Selected Citations

Main menu

User menu

Search

drug nephrotoxicity

Pages

About

Author Information

More information